compounded semaglutide average weight loss Affordable Injections Semaglutide weight loss dosage chart

Weight at the start, diet, activity, and dosage are some of the things that affect the outcome

Because of these combined pathways, retatrutide is often described in research literature as a triple agonist peptide

Namkung J, Kim H, Park S

European Clinical Trials Database (EudraCT)

GLP-1 receptor agonists, a class of drugs originally developed for type 2 diabetes and obesity that have recently transformed metabolic medicine, target the downstream consequences of that hormonal withdrawal: dysregulated energy metabolism, inflammation, and shifts in body composition

While most GLP-1 trials haven't isolated menopausal populations, general weight-loss data shows 10-15% average loss with semaglutide, with tirzepatide achieving up to 20% loss